Onyx Pharmaceuticals, Inc. (ONXX)
A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.
Recs
TigerPackFund
(95.97)
Submitted: 11/9/2009 9:28:46 PM :
Start Price:
$26.64
ONXX Score:
+4.99
portefeuille - http://caps.fool.com/player/portefeuille.aspx
Recs
rpgizzle
(76.88)
Submitted: 11/5/2009 7:53:14 PM :
Start Price:
$26.65
ONXX Score:
+2.04
Promising cancer drugs that target blood vessel growth in tumors. It already has Nexavar which is a proven drug. It also has more drugs in the pipeline. Could also be takeover target eventually.
Recs
mizims
(44.79)
Submitted: 10/27/2009 2:36:05 AM :
Start Price:
$25.26
ONXX Score:
+8.65
my be a bore in the short term, but long term it will be a winner
Recs
alcear
(67.26)
Submitted: 10/22/2009 2:58:05 PM :
Start Price:
$25.64
ONXX Score:
+9.21
1word..Carfilzomib. Showing very positive results in phase 2 trials. My wife is in a trial for multiple myaloma. Looks like a home run for this drug like thalidamide was for Celgene.
Recs
HIGHG33K
(< 20)
Submitted: 10/21/2009 3:58:19 PM :
Start Price:
$25.17
ONXX Score:
+10.20
Well undervalue mid-sized biotech with a buyout potential over $50 and possible positive clinical results in 2 years.
Recs
SmallPimpin
(98.29)
Submitted: 8/5/2009 2:43:46 PM :
Start Price:
$31.24
ONXX Score:
-20.35
Mmm...pharmaceuticals...
Recs
GravityGun
(< 20)
Submitted: 8/3/2009 11:40:31 AM :
Start Price:
$36.00
ONXX Score:
-32.62
I think people will use this drug for alternative cancer treatments before approved by the FDA. It's already greenlighted in many countries abroad.
Recs
jjam79095
(56.92)
Submitted: 7/27/2009 11:49:36 AM :
Start Price:
$35.16
ONXX Score:
+33.36
Good market but stale growth right now.
Recs
bothisellhigher
(43.94)
Submitted: 7/23/2009 4:08:06 PM :
Start Price:
$35.77
ONXX Score:
-37.86
Target 40.50
Recs
jbs4radio
(< 20)
Submitted: 7/3/2009 3:25:09 AM :
Start Price:
$31.00
ONXX Score:
-16.32
Russell 2000 expected growth 26% or better
Recs
euphorbus
(92.67)
Submitted: 6/3/2009 10:20:16 PM :
Start Price:
$25.26
ONXX Score:
-6.96
Onyx will get bought out within two years.
Recs
Recs
pick1998
(76.05)
Submitted: 2/24/2009 7:39:22 AM :
Start Price:
$32.27
ONXX Score:
-62.09
ONXX reports strong revenue growth on Nexavar sales. 2008 Nexava Net sales of $678M, 82% annual growth, makes 2008 the first full year profitable although more R&D cost. New indications are progressing well. A long position for a long time.
Recs
abacusdude
(89.64)
Submitted: 12/26/2008 1:32:28 PM :
Start Price:
$33.22
ONXX Score:
-44.71
The Obama Plan for Healthcare:
1) Barack Obama will make health insurance affordable and accessible to all:
The Obama-Biden plan provides affordable, accessible health care for all Americans, builds on the existing healthcare system, and uses existing providers, doctors and plans to implement the plan.
2) Obama will lower health care costs:
The Obama plan will lower health care costs by $2,500 for a typical family by investing in health information technology, prevention and care coordination.
3) Promote public health:
Obama and Biden will require coverage of preventive services, including cancer screenings, and will increase state and local preparedness for terrorist attacks and natural disasters.
"http://www.barackobama.com/issues/healthcare/"
Recs
juanocb12
(69.08)
Submitted: 9/8/2008 12:05:40 PM :
Start Price:
$37.01
ONXX Score:
-14.73
Possible buyout by Bayer
Recs
LonewolfNC
(64.70)
Submitted: 8/9/2008 12:37:16 PM :
Start Price:
$38.93
ONXX Score:
-15.55
Onxx baby!
Recs
BayAreaVoice
(< 20)
Submitted: 8/7/2008 1:13:41 PM :
Start Price:
$37.89
ONXX Score:
-14.43
Tough crowd among their analysts & investors. Shares fall 3.7% even with back to back quarterly profit and expansion abroad. Best is yet to come.
Recs
poling2482
(20.56)
Submitted: 7/24/2008 2:17:35 PM :
Start Price:
$38.39
ONXX Score:
-16.77
A good buy at around $38. Great company with many new ideas will see a $50 price in near future.
Recs
xb70cv
(< 20)
Submitted: 6/29/2008 2:31:36 AM :
Start Price:
$35.50
ONXX Score:
-9.58
seems to have several products ready to take-off
Recs
pranilbalram
(69.39)
Submitted: 5/8/2008 4:56:00 PM :
Start Price:
$34.28
ONXX Score:
-0.38
Nexavar will bring in revenue this year. Strong balance sheet but lots of risk involved.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 71 1 2 3 4 Next »